Maternal & Child Health Research Institute (MCHRI)
Showing 121-140 of 143 Results
-
Thomas Sudhof
Avram Goldstein Professor in the School of Medicine, Professor of Neurosurgery and, by courtesy, of Neurology and Neurological Sciences and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsInformation transfer at synapses mediates information processing in brain, and is impaired in many brain diseases. Thomas Südhof is interested in how synapses are formed, how presynaptic terminals release neurotransmitters at synapses, and how synapses become dysfunctional in diseases such as autism or Alzheimer's disease. To address these questions, Südhof's laboratory employs approaches ranging from biophysical studies to the electrophysiological and behavioral analyses of mutant mice.
-
Ayesha Sujan
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
BioAyesha C. Sujan, PhD, is a licensed clinical psychologist with specialized clinical training in pediatric pain psychology and extensive research experience in pharmacoepidemiology, particularly in using large administrative datasets to study central nervous system medication and substance use during pregnancy. She is currently a postdoctoral fellow under the primary mentorship of Dr. Jennifer Rabbitts, Chief of Pediatric Pain, in the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine, and is supported by an NIH T32 training grant (T32GM089626) focused on developing leaders in academic anesthesiology and pain medicine research. In addition to contributing to Dr. Rabbitts’ NIH-funded research on mechanisms and treatment of pain in youth undergoing surgery, she leads independent studies on pediatric chronic abdominal pain and disorders of gut–brain interaction, with a growing focus on central nervous system medication treatment for these conditions. Clinically, she conducts psychosocial assessments and provides evidence-based pain psychology treatment one day per week (20% FTE) in the outpatient pediatric pain management clinic at Stanford University School of Medicine, ensuring strong clinical grounding and translational relevance of her research program.
-
Mariella Suleiman, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Mariella Suleiman is a board-certified, fellowship-trained psychiatrist with Stanford Health Care. She is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences, Division of Medical Psychiatry at Stanford University School of Medicine.
Dr. Suleiman has special training in treating women's reproductive mental health conditions across the lifespan, including but not limited to perinatal mood and anxiety disorders (PMADs), premenstrual dysphoric disorder (PMDD), and perimenopausal disorders. She also specializes in psychosomatic medicine, which focuses on appropriate psychological care for a range of reactions to illness. At Stanford Medicine, she works with the Consultation-Liaison Psychiatry Service, which provides treatment recommendations to manage psychiatric conditions while patients are hospitalized.
Dr. Suleiman’s research interests span advocacy to improve regulation of medications to treat mania in bipolar disorder (valproate) in the childbearing years, clinical approaches to treating agitation during pregnancy, and evidence-based management of bipolar disorder during and after pregnancy.
Dr. Suleiman has published her research in peer-reviewed journals such as The Journal of Clinical Psychiatry, Academic Psychiatry, The Primary Care Companion for CNS Disorders, and CNS Drugs. She has presented to her peers at international, national, and regional meetings, including those of the Academy of Consultation-Liaison Psychiatry (ACLP), the American Association for Directors of Psychiatric Residency Training (AADPRT), and the Royal Health Awareness Society (RHAS) of Jordan.
Dr. Suleiman is a member of the ACLP, the American Psychiatric Association (APA), the Jordan Medical Association (JMA), and the Northern California Psychiatric Society (NCPS). -
Pervez Sultan
Professor of Anesthesiology, Perioperative and Pain Medicine (Obstetrics) and, by courtesy, of Obstetrics and Gynecology
BioDr. Pervez Sultan is a Professor in the department of Anesthesiology, Perioperative and Pain Medicine and (By Courtesy) in the department of Obstetrics and Gynecology at Stanford University School of Medicine. He is also an Honorary Professor at University College London in the department of Targeted Intervention. His research interests include defining, characterizing, measuring and improving postpartum recovery.
He has authored over 185 peer reviewed publications and presented the Ostheimer Lecture at the 2023 Society for Obstetric Anesthesia and Perinatology annual meeting.
Dr. Sultan is an NIH funded researcher. He is the principal investigator for 2 R01 grants: one developing and validating a measure for postpartum sleep and another exploring interventions for PTSD after childbirth. He is also a co-investigator for a Maternal Centers of Excellence U54 award exploring Inequities in Hemorrhage-related Severe Maternal Morbidity and is a Co-Investigator on a T90 grant.
Dr. Sultan is an elected member of the Association of University Anesthesiologists. He serves on the Society for Obstetric Anesthesia and Perinatology (SOAP) Board as the Director from Academic Practice, and serves on the Annual Meeting and Live Events and Research Committees.
Dr. Sultan is a former Arline and Pete Harman Endowed Faculty Scholar of the Stanford Maternal and Child Health Research Institute at Stanford University and a previous recipient of the UK National Institute of Academic Anesthesia Research Award.
NIH Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/pervez.sultan.1/bibliography/public/
Researchgate profile: https://www.researchgate.net/profile/Pervez_Sultan2
Google Scholar profile: https://scholar.google.com/citations?user=Z2ftv_IAAAAJ&hl=en
Twitter: @PervezSultanMD -
Meghan Sumner
Associate Professor of Linguistics
BioMeghan Sumner received her PhD in Linguistics at Stony Brook University. After completing her PhD, she was an NIH NRSA Postdoctoral Fellow in Cognitive Psychology. She has been at Stanford University since 2007, where she is now an Associate Professor of Linguistics and the Director of the Stanford Phonetics Lab, where she investigates variation and spoken language understanding.
Meghan’s research sits at the intersection of acoustic phonetics, language use and variation, social meaning, and cognitive psychology. She investigates attention, perception, recognition, memory, and comprehension within and across individuals, groups, and languages, aiming to understand how different components of spoken language understanding work together. She and her students are testing the predictions of and hope to contribute to the development of a dynamic adaptive socially-anchored model of spoken language understanding. For the past twenty years, her work has focused on diverse talker and listener populations, drawing on variation to address issues in linguistics and psychology related to representation, asymmetries in memory, social effects in spoken language recognition, familiarity, experience, and categorization.
She is currently a Stanford Impact Labs Design Fellow, working with public institutions and advocacy groups to apply language-based social science methods to increase protections for children living with domestic violence. -
Louise Y Sun
Professor of Anesthesiology, Perioperative and Pain Medicine (Cardiac)
BioDr. Louise Sun is a Professor of Anesthesiology, Perioperative and Pain Medicine and Director of Cardiovascular Research. She is an Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES) in Toronto. Prior to this, she was an Associate Professor of Anesthesiology and Epidemiology, Director of Big Data and Health Bioinformatics Research at the University of Ottawa Heart Institute, and a Clinical Research Chair in Big Data and Cardiovascular Outcomes at the University of Ottawa.
Dr. Sun received her medical degree from McMaster University. She completed her anesthesiology residency at the University of Ottawa and her Masters of Science in Epidemiology at the Harvard School of Public Health, followed by a clinical and research fellowship in cardiac anesthesia at the University of Toronto. She then joined the Division of Cardiac Anesthesiology at the University of Ottawa Heart Institute and was cross appointed as an ICES faculty member.
Dr. Sun’s areas of clinical focus are hemodynamic monitoring and heart failure. Her methodologic areas of focus are the conduct of population-based cohort studies using large healthcare databases; predictive analytics; sex and gender epidemiology; patient engagement; innovative methods for data processing and warehousing; and software and applications development. Her research leverages big data and digital technology to bridge key gaps in the delivery of care and outcomes for patients with heart failure and/or undergoing cardiovascular interventions, zooming in on sex/gender and personalized care. She holds several patents and collaborates with health authorities and policy makers to evaluate and report on models of cardiac healthcare delivery.
Dr. Sun is active in the scientific community. She sits on a number of US, Canadian and international editorial boards and scientific and grant review committees, and collaborates nationally and internationally on a variety of population health and data science initiatives. Her patient-centered research program aims to improve access to care and outcomes, focusing on personalized risk stratification and long-term, patient-defined outcomes. She has authored over 100 peer-reviewed papers and published in leading clinical journals including JAMA, JAMA Cardiology, JAMA Internal Medicine, Circulation, JACC, Diabetes Care, and Anesthesiology. Her research program has been well funded by the Canadian Institutes of Health Research (CIHR), the Heart and Stroke Foundation of Canada, and the Ontario Ministry of Health. -
Vivien Kon-Ea Sun
Clinical Associate Professor, Pediatrics
BioVivien Sun is a pediatric hospitalist and Clinical Associate Professor within Stanford’s Division of Pediatric Hospital Medicine. She practices at California Pacific Medical Center and Stanford Healthcare Tri-Valley. Vivien’s interests include advocacy, medical education, and professional development.
-
Wenfei Sun
Assistant Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsWe explore neural circuits regulating memory and systemic metabolism, integrating neuroscience and metabolic biology to tackle cognitive decline and metabolic disorders.
-
Yang Sun, MD, PhD
Professor of Ophthalmology
Current Research and Scholarly InterestsWe are interested in the role of inositol phosphatases in eye development and disease, using both animal models and human disease tissue. We are a translational laboratory seeking to understand the basic function of proteins as well as developing therapeutic strategies for clinical trials.
-
Zijie Sun
Professor of Urology, Emeritus
Current Research and Scholarly InterestsWe focus on understanding the molecular mechanism of transcription factors that govern the transformation of normal cells to a neoplastic state. We are especially interested in nuclear hormone action and its interactions with other signaling pathways in tumor development and progression.
-
Philip Sunshine
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsMy primary interests are in the area of neonatal nutrition and developmental gastroenterology. The use of parenteral nutrition in very low birth weight infants, and the introduction of early enteral feeding to stimulate gastrointestinal maturation are my specific areas of investigative endeavors.
-
John B. Sunwoo, MD
Edward C. and Amy H. Sewall Professor in the School of Medicine and Professor, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy laboratory is focused on two primary areas of research: (1) the immune response to head and neck cancer and to a tumorigenic population of cells within these malignancies called cancer stem cells; (2) the developmental programs of a special lymphocyte population involved in innate immunity called natural killer (NK) cells; and (3) intra-tumor and inter-tumor heterogeneity.
-
Katrin J Svensson
Associate Professor of Pathology
Current Research and Scholarly InterestsMolecular metabolism
Protein biochemistry
Cell biology and function
Animal physiology -
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances.
